PMC:6988269 / 21978-22234 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T99","span":{"begin":38,"end":42},"obj":"Body_part"}],"attributes":[{"id":"A99","pred":"fma_id","subj":"T99","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"Technical qualification data based on cell culture materials and synthetic constructs, as well as results from exclusivity testing on 75 clinical samples, were included in the first version of the diagnostic protocol provided to the WHO on 13 January 2020."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T225","span":{"begin":38,"end":42},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T226","span":{"begin":123,"end":130},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"Technical qualification data based on cell culture materials and synthetic constructs, as well as results from exclusivity testing on 75 clinical samples, were included in the first version of the diagnostic protocol provided to the WHO on 13 January 2020."}

{"project":"LitCovid-sentences","denotations":[{"id":"T200","span":{"begin":0,"end":256},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Technical qualification data based on cell culture materials and synthetic constructs, as well as results from exclusivity testing on 75 clinical samples, were included in the first version of the diagnostic protocol provided to the WHO on 13 January 2020."}

{"project":"LitCovid-PubTator","denotations":[{"id":"371","span":{"begin":65,"end":85},"obj":"Species"}],"attributes":[{"id":"A371","pred":"tao:has_database_id","subj":"371","obj":"Tax:32630"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Technical qualification data based on cell culture materials and synthetic constructs, as well as results from exclusivity testing on 75 clinical samples, were included in the first version of the diagnostic protocol provided to the WHO on 13 January 2020."}